We are live on ! Find out more
WA

WestEnd Advisors Portfolio holdings

AUM $4.14B
1-Year Est. Return 15.99%
This Fund
S&P 500
This Quarter Est. Return
+1.26%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$963M
AUM Growth
-$99M
Cap. Flow
-$111M
Cap. Flow %
-11.58%
Top 10 Hldgs %
40.11%
Holding
51
New
2
Increased
19
Reduced
24
Closed
–

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$37M
2
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$7.9M
3
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$7.85M
4
KHC icon
Kraft Heinz
KHC
+$5M
5
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$4.98M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$38.2M
2
MA icon
Mastercard
MA
+$18.3M
3
TJX icon
TJX Companies
TJX
+$16.5M
4
MSFT icon
Microsoft
MSFT
+$14.9M
5
UNH icon
UnitedHealth
UNH
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.53%
2 Financials 19.02%
3 Consumer Staples 12.18%
4 Communication Services 11.62%
5 Technology 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
51
DELISTED
Celgene Corp
CELG
$317 ﹤0.01%
4
– –
1 2
3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $4.12B AUM
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return

WestEnd Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, WestEnd Advisors held 51 positions worth $963M, down 9.3% from $1.06B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

WestEnd Advisors withdrew a net $111M in Q2 2018, reducing 24 holdings. Its largest reduction was Allergan plc, cutting an estimated $38.2M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, WestEnd Advisors opened a new position in Procter & Gamble worth $38.4M.

  • WestEnd Advisors's largest Q2 2018 buy was Procter & Gamble: 491,624 shares worth $38.4M.
  • WestEnd Advisors added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2018, an estimated $7.9M increase.
  • WestEnd Advisors's biggest Q2 2018 reduction was Allergan plc, cutting an estimated $38.2M.
  • WestEnd Advisors's ten largest holdings make up 40% of its $963M portfolio in Q2 2018.
  • WestEnd Advisors opened 2 new positions and closed 0 in Q2 2018.
  • WestEnd Advisors's portfolio value fell 9.3% quarter-over-quarter to $963M.

Based on WestEnd Advisors's 13F filing for Q2 2018, filed 26 Jul 2018.